TGFB1 and colorectal carcinoma: Given activin and TGF-β’s overlap in their canonical pathway and divergence in their downstream oncogenic signaling as well as the frequent co-occurrence of mutations in their respective receptors26–28, we here focus on understanding the mechanisms of activin and TGF-β crosstalk in metastatic signaling in CRC.